amantadine hydrochloride

Generic: amantadine hydrochloride

Labeler: st. mary's medical park pharmacy
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name amantadine hydrochloride
Generic Name amantadine hydrochloride
Labeler st. mary's medical park pharmacy
Dosage Form CAPSULE
Routes
ORAL
Active Ingredients

amantadine hydrochloride 100 mg/1

Manufacturer
ST. MARY'S MEDICAL PARK PHARMACY

Identifiers & Regulatory

Product NDC 60760-779
Product ID 60760-779_3dd7e808-e0ec-8514-e063-6394a90a9f34
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA212044
Listing Expiration 2026-12-31
Marketing Start 2020-05-21

Pharmacologic Class

Classes
influenza a m2 protein inhibitor [epc] m2 protein inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 60760779
Hyphenated Format 60760-779

Supplemental Identifiers

RxCUI
849389
UNII
M6Q1EO9TD0

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name amantadine hydrochloride (source: ndc)
Generic Name amantadine hydrochloride (source: ndc)
Application Number ANDA212044 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 100 mg/1
source: ndc
Packaging
  • 30 CAPSULE in 1 BOTTLE, PLASTIC (60760-779-30)
source: ndc

Packages (1)

Ingredients (1)

amantadine hydrochloride (100 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "3dd7e808-e0ec-8514-e063-6394a90a9f34", "openfda": {"unii": ["M6Q1EO9TD0"], "rxcui": ["849389"], "spl_set_id": ["3dd7f2a6-5a91-81a2-e063-6294a90a33db"], "manufacturer_name": ["ST. MARY'S MEDICAL PARK PHARMACY"]}, "finished": true, "packaging": [{"sample": false, "description": "30 CAPSULE in 1 BOTTLE, PLASTIC (60760-779-30)", "package_ndc": "60760-779-30", "marketing_start_date": "20250826"}], "brand_name": "Amantadine Hydrochloride", "product_id": "60760-779_3dd7e808-e0ec-8514-e063-6394a90a9f34", "dosage_form": "CAPSULE", "pharm_class": ["Influenza A M2 Protein Inhibitor [EPC]", "M2 Protein Inhibitors [MoA]"], "product_ndc": "60760-779", "generic_name": "Amantadine Hydrochloride", "labeler_name": "ST. MARY'S MEDICAL PARK PHARMACY", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Amantadine Hydrochloride", "active_ingredients": [{"name": "AMANTADINE HYDROCHLORIDE", "strength": "100 mg/1"}], "application_number": "ANDA212044", "marketing_category": "ANDA", "marketing_start_date": "20200521", "listing_expiration_date": "20261231"}